Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NUTX · against 405 other Healthcare companies of similar size
Ranked #63 of 406 · scores higher than 84% of peers
Bars: peers in each 10-point band of the growth score44 peers with a growth score of 80–89, including NUTX · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | NUTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 412 reported | 6.9% | 5.3% | 55% | 33% | |
| Earnings per share growthHigher is better · 225 reported | 7.9% | 8.3% | 50% | 33% | |
| 3-year revenue growthHigher is better · 398 reported | 62.5% | 6.0% | 95% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 2.1B USD | 99 | 96 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 60 | 158.6B INR (≈$1.9B) | 85 | 70 | |
| 60 | 1.9B USD | 85 | 47 | |
| 63 | 1.1B USD | 84 | 50 | |
| 63 | 1.3B CHF (≈$1.5B) | 84 | 48 | |
| 63 | 1.2B USD | 84 | 75 | |
| 66 | 13.5B CNY (≈$1.9B) | 83 | 67 | |
| 66 | 1.8B USD | 83 | 80 | |
| 66 | 1.4B USD | 83 | 53 | |
| 66 | 2.0B USD | 83 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score